ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,554.00
-2.26%
Dow Jones
37,986.40
0.56%
Brent Oil
86.625
0.00%
Bitcoin
63,826.38
0.00%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Argen X SE (ARGX) Quote

Argen X SE

Argen X SE (ARGX)

argenx SE
337.30
-4.70
(-1.37%)
Closed April 20 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
337.30
Bid
335.10
Ask
341.50
Volume
35,871
335.10 Day's Range 341.10
271.00 52 Week Range 494.10
Market Cap
19.283B
Previous Close
342.00
Open
338.00
Last Trade
5
@
337.3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
61,462
Shares Outstanding
57,169,000
Dividend Yield
-
PE Ratio
-65.35
Earnings Per Share (EPS)
-5.16
Revenue
1.27B
Net Profit
-295.05M

About Argen X SE

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.argenx.com
Headquarters
Amsterdam, North Holland, Nld
Founded
1970
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 342.00 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 494.10 €.

Argen X currently has 57,169,000 shares outstanding. The market capitalization of Argen X is 19.28 € billion. Argen X has a price to earnings ratio (PE ratio) of -65.35.

ARGX Latest News

More News

argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease

ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over...

April 16 2024
GlobeNewswire Inc.

argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease

         RHO study supports proof-of-concept in primary Sjogren’s disease Decision informed by favorable safety profile and consistency across efficacy and biomarker measures March 27, 2024...

March 27 2024
GlobeNewswire Inc.

argenx Announces Annual General Meeting of Shareholders on May 7, 2024

March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

March 26 2024
GlobeNewswire Inc.

argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia

VYVGART® now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents first global approval for VYVGART in ITP...

March 26 2024
GlobeNewswire Inc.

argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting

ADHERE data presentation will highlight first potential innovation for CIDP patients in 30 years Abstracts reflect real-world value and consistent efficacy and safety profile associated with...

March 07 2024
GlobeNewswire Inc.

argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

$374 million in fourth quarter and $1.2 billion in full year global net product sales sBLA for VYVGART® Hytrulo for CIDP accepted for priority review by FDA with PDUFA target action date of...

February 29 2024
GlobeNewswire Inc.

argenx to Present at Upcoming Investor Conferences

February 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

February 26 2024
GlobeNewswire Inc.

argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024

February 22, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

February 22 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-16.3-4.60972850679353.6359.6334.745148347.22482745DE
4-31.8-8.6155513411369.1378.3334.743471358.59374075DE
12-13.9-3.95785876993351.2380.5322.561462357.77833326DE
26-126.1-27.2119119551463.4475.827166219378.06380374DE
52-3.7-1.08504398827341494.127162346397.35220376DE
156100.142.2006745363237.2494.1201.465592335.12111823DE
260233.2224.015369837104.1494.193.0580557249.75175561DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

Discussion

View Full Feed
Hosai Hosai 3 minutes ago
Crescent yes I remember him saying something like that almost as an aside where I think he said something like "either in the peer review or the presentation" but can't remember where it was in the 30 min video now.
AVXL
ksquared ksquared 6 minutes ago
Good for her. Sounds like she could play for free.
Hope she does as well professionally as she has done on the college level...
And has a lot of fun doing it.
$PennyMover $PennyMover 11 minutes ago
Nice info, DOJ needs to get moving

https://www.marijuanamoment.net/ahead-of-4-20-white-house-says-biden-has-been-very-clear-in-supporting-marijuana-decriminalization-but-admin-is-awaiting-doj-rescheduling-action/
SGDH
ksquared ksquared 13 minutes ago
Ouch... Bet Kunstler didn't/doesn't...
get laid much.
Preciouslife1 Preciouslife1 13 minutes ago
Awesome baseball ⚾️ interview of Mickey, Duke and Willie

https://www.facebook.com/share/v/vipL88fBGWqAMcDi/?mibextid=TGkgF5
Inwestor69 Inwestor69 18 minutes ago
GIFX has 329 registered followers on Ihub.
Posters 1205.
Posts (Total) 72492.
Quite an impressive number.
Over time, their number will begin to increase.
GIFX
jimr1717 jimr1717 18 minutes ago
Will the next product be SPG+ platinum used mulch?
Maybe they will start paying people for their old bed mulch and dig it out for free.

Lmao at this sham.

~~~ No One Is Fooled ~~~
IFUS
ITYS ITYS 19 minutes ago
Key to any company debt is conversion restrictions, I hate stupid people that can't read company financials.
THIS management is a SOLID EDUCATED TEAM, this idiot invests in companies that have a 1 man band like GEVI and its run by a 32 year old kid that worked as a coast guard?
GEVI
ITYS ITYS 19 minutes ago
Key to any company debt is conversion restrictions, I hate stupid people that can't read company financials.
THIS management is a SOLID EDUCATED TEAM, this idiot invests in companies that have a 1 man band like GEVI and its run by a 32 year old kid that worked as a coast guard?
GEVI
ChrisMc75 ChrisMc75 21 minutes ago
The same people that are selling are the ones buying. Like I said they will trade this back down to nothing. Unless Kgkg does something to suck up those shares this is what bagholders like us are stuck with. This will only push away legitimate investors. Thus making the company worthless to everyon
KGKG
Grouse Hunter Grouse Hunter 23 minutes ago
This feels like the movie Office Space where the TPS Reports aren’t being submitted with a cover sheet and management is all upset. I find it hard to believe Delfin just a few weeks ago thought they were on the final steps to completion with MARAD and now everything is back to square one. The one
TGLO
StevenDice StevenDice 24 minutes ago
You know there is a band by the name of “Insane Clown Posse”. In fact, I happened to be on a commercial flight and sat next to a guy who called himself “ Corporal Thompson“. Turned out he was the front man for Insane Clown Posse. Couldn’t wait to get off that flight. Just listening to that dude wa
LWLG
PEACHMAN PEACHMAN 24 minutes ago
https://twitter.com/ImpactfusionI/status/1781634187721650669
PEACHMAN PEACHMAN 28 minutes ago
https://twitter.com/ImpactfusionI/status/1781634187721650669
IFUS
mrdecember123 mrdecember123 33 minutes ago
and our timing is cool- due to it being an election year, i presuppose the overall mkt will have few fears and far less volatility--------------------------------------------------------------------------------------i feel snug as a bug going into november with our pays prospects. I'm not selling my
PAYS
Pokerpro05 Pokerpro05 37 minutes ago
This company sure is quiet and slow with any news. Anyone think they will merge or acquire anything in the near term?

Pokerpro05
DTGI
JAB65 JAB65 38 minutes ago
Senor made some very good points as did others in post that preceded your post and followed late last night, late for an east coast boy. There are many nuances here that we just don't know but it is not back to square one, that much I'm pretty sure of. Just another Delfin bump in the road. This saga
TGLO
Nelson2 Nelson2 40 minutes ago
Often times companies make themselves lean setting up for a buyout
Sound familiar?

GLTU
BB
StevenDice StevenDice 42 minutes ago
Damn brah, arrows are sharp!
LWLG
Beano1969 Beano1969 43 minutes ago
Come on .0002/.0003🤞🍀


🤣
VGLS
floridaboy floridaboy 43 minutes ago
https://www.thewrap.com/lionsgate-spac-merger-studio-spinoff-expected-close-may/
SAPX
SkeBallLarry SkeBallLarry 45 minutes ago
Caitlin Clark to sign massive endorsement deal with Nike >

https://www.msn.com/en-us/sports/other/caitlin-clark-to-sign-massive-endorsement-deal-with-nike-amid-wnba-contract-controversy/ar-BB1lPnXO
ChrisMissing ChrisMissing 47 minutes ago
I would suggest George that like most things the company does it’s hiring practices is in stealth mode and has to be going into a huge hiring mode. Partnership looming and EMA submission I suspect that we will need many more people. Like some of the other senior leaders we usually don’t find out u
AVXL
monocle monocle 48 minutes ago
It seems that all narratives not yours are spun and false. 🤔 🧐

Warren Buffett can't invest because he has a conflict of interest? False narrative

The high redemption rate that was predicted before a bank failure was caused by a bank failure? False narra
NB

Your Recent History

EU
ARGX
Argen X
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved